Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis

BACKGROUND: Currently, there is no topical treatment available for any form of cutaneous leishmaniasis (CL) in most of the endemic areas. The aim of the current study was to develop a topical nano-liposomal Amphotericin B (AmB) for the treatment of CL. METHODOLOGY/PRINCIPAL FINDINGS: Liposomes conta...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaafari, Mahmoud Reza, Hatamipour, Mahdi, Alavizadeh, Seyedeh Hoda, Abbasi, Azam, Saberi, Zahra, Rafati, Sima, Taslimi, Yasaman, Mohammadi, Akram Miramin, Khamesipour, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Includes articles from the special issue “Novel therapies for cutaneous leishmaniasis”, pp. 106 - 179
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904837/
https://www.ncbi.nlm.nih.gov/pubmed/31582344
http://dx.doi.org/10.1016/j.ijpddr.2019.09.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904837/
https://www.ncbi.nlm.nih.gov/pubmed/31582344
http://dx.doi.org/10.1016/j.ijpddr.2019.09.004

Ejemplares similares